9WHE
A novel, covalent and highly synthetically accessible SARS-CoV-2 Mpro chloroacetamide inhibitor
This is a non-PDB format compatible entry.
Summary for 9WHE
| Entry DOI | 10.2210/pdb9whe/pdb |
| Descriptor | 3C-like proteinase, (2~{R})-~{N}-[4,4-bis(fluoranyl)cyclohexyl]-2-[ethanoyl-[4-(1,2-thiazol-5-yl)phenyl]amino]-2-pyrazin-2-yl-ethanamide, ACETATE ION, ... (5 entities in total) |
| Functional Keywords | inhibitor, complex, antiviral, covalent, hydrolase |
| Biological source | Severe acute respiratory syndrome coronavirus 2 |
| Total number of polymer chains | 1 |
| Total formula weight | 35034.87 |
| Authors | Zagribelnyy, B.,Zhavoronkov, A. (deposition date: 2025-08-26, release date: 2025-09-17, Last modification date: 2025-10-15) |
| Primary citation | Zagribelnyy, B.,Zhavoronkov, A. A novel, covalent and highly synthetically accessible SARS-CoV-2 Mpro chloroacetamide inhibitor To Be Published, |
| Experimental method | X-RAY DIFFRACTION (1.82 Å) |
Structure validation
Download full validation report






